Banner for leaf pages 2

Ertapenem

Also known as Invanz

Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz. It is structurally very similar to meropenem in that it possess a 1-β-methyl group.

Source: Wikipedia

Estimated Total Cost: $450.49 for an average of 7 days supply

What is it prescribed for?

Patients are most commonly prescribed ertapenem to treat pyogenic skin infection, blastomycosis, rabies, and west nile virus.

What drug interactions are known?

Do not take ertapenem if you are taking any of the following:

Critical Interactions

Significant Interactions


Ajax-loader Loading...